{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:56:22Z","timestamp":1761101782918},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.atherosclerosis.2006.10.014","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T21:26:52Z","timestamp":1164835612000},"page":"116-124","source":"Crossref","is-referenced-by-count":11,"title":["C-terminal apolipoprotein E-derived peptide, Ep1.B, displays anti-atherogenic activity"],"prefix":"10.1016","volume":"194","author":[{"given":"Leila","family":"Bocksch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly J.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erbin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasinath","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Munuswamy-Ramanujam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagirath","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib1","doi-asserted-by":"crossref","first-page":"15745","DOI":"10.1016\/S0021-9258(18)82318-3","article-title":"Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization","volume":"268","author":"Westerlund","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib2","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1073\/pnas.91.10.4431","article-title":"The two-receptor model of lipoprotein clearance: tests of the hypothesis in \u201cknockout\u201d mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins","volume":"91","author":"Ishibashi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1126\/science.2063194","article-title":"Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E","volume":"252","author":"Wilson","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1568006013337944","article-title":"Apolipoprotein E: possible therapeutic target for atherosclerosis","volume":"1","author":"Bocksch","year":"2001","journal-title":"Curr Drug Targets: Card Haematol Dis"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.RES.0000082978.92494.B1","article-title":"Aorta of apoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes","volume":"93","author":"Hoen","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib9","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0002-9440(10)64823-7","article-title":"Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice","volume":"157","author":"Zhu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib10","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1172\/JCI118271","article-title":"Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice","volume":"96","author":"Bellosta","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib11","first-page":"1","article-title":"Subphysiologic apolipoprotein E (apoE) plasma levels inhibit neointimal formation after arterial injury in apoE-deficient mice","volume":"2","author":"Wientgen","year":"2004","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI115639","article-title":"Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits","volume":"89","author":"Yamada","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib14","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1016\/S0021-9258(18)98578-9","article-title":"Only multimers of a synthetic peptide of human apolipoprotein E are biologically active","volume":"266","author":"Dyer","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0006-291X(88)90202-1","article-title":"Inhibition of lymphocyte proliferation by synthetic peptides homologous to human plasma apolipoproteins B and E","volume":"154","author":"Cardin","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib16","doi-asserted-by":"crossref","first-page":"25043","DOI":"10.1074\/jbc.M102357200","article-title":"Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation","volume":"276","author":"Swertfeger","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1074\/jbc.272.1.89","article-title":"Apolipoprotein E inhibits platelet aggregation through the l-arginine: nitric oxide pathway","volume":"272","author":"Riddell","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib18","doi-asserted-by":"crossref","first-page":"18913","DOI":"10.1074\/jbc.M909644199","article-title":"Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan","volume":"275","author":"Klezovitch","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/prep.1999.1144","article-title":"Carboxyl-terminal domain of human apolipoprotein E: expression, purification, and crystallization","volume":"17","author":"Forstner","year":"1999","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1172\/JCI18607","article-title":"Disruption of TGF-\u03b2 signaling in T cells accelerates atherosclerosis","volume":"112","author":"Robertson","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib21","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/01.ATV.0000084636.01328.C7","article-title":"Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice","volume":"23","author":"Murphy","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/15271","article-title":"Requirements for CD154 in the progression of atherosclerosis","volume":"5","author":"Lutgens","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.CIR.0000109140.51366.72","article-title":"Toll-like receptor 4 is involved in outward artery remodeling","volume":"109","author":"Hollestelle","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib24","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.ATV.0000128849.12617.f4","article-title":"Atherosclerosis in the apolipoprotein E-deficient mouse\u2014a decade of progress","volume":"24","author":"Meir","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0161-5890(96)00022-3","article-title":"Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules","volume":"33","author":"Rider","year":"1996","journal-title":"Mol Immunol"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/371250a0","article-title":"Peptides determine the lifespan of MHC II molecules in the antigen-presenting cell","volume":"371","author":"Nelson","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib27","doi-asserted-by":"crossref","first-page":"18563","DOI":"10.1074\/jbc.M209683200","article-title":"Serp-1, a viral anti-inflammatory Serpin, regulates cellular serine proteinase and Serpin responses to vascular injury","volume":"278","author":"Dai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib28","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1073\/pnas.0334864100","article-title":"Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines","volume":"100","author":"Proudfoot","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib29","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/S0021-9258(18)68778-2","article-title":"Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains","volume":"263","author":"Wetterau","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib30","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1016\/S0021-9258(18)68779-4","article-title":"Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains","volume":"263","author":"Aggerbeck","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib31","doi-asserted-by":"crossref","first-page":"22358","DOI":"10.1016\/S0021-9258(17)31797-0","article-title":"Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms","volume":"269","author":"Dong","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib32","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1073\/pnas.0403259101","article-title":"Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques","volume":"101","author":"Llodra","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2006.10.014_bib33","first-page":"20","article-title":"Dendritic cells and Immune regulation in the pathogenesis and prevention of Type 1 diabetes","volume":"28","author":"Summers","year":"2004","journal-title":"Can J Diabetes"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006006095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006006095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:44:56Z","timestamp":1628149496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915006006095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0021915006006095"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.10.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}